Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

21.26
-0.3100-1.44%
Volume:23.62K
Turnover:501.53K
Market Cap:3.40B
PE:-7.50
High:21.33
Open:21.24
Low:21.09
Close:21.57
52wk High:27.30
52wk Low:12.58
Shares:159.85M
Float Shares:151.07M
Volume Ratio:0.48
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8353
EPS(LYR):-2.9700
ROE:-54.93%
ROA:-29.15%
PB:4.07
PE(LYR):-7.16

Loading ...

Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Major Issues Report

Form 8-K - Current report
Dec 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]